162 results
6-K
EX-99.1
NEPTF
Neptune Wellness Solutions Inc
19 Nov 08
Current report (foreign)
12:00am
the pharmacokinetic profile of Neptune Krill Oil NKO®. The objective of the trial was to evaluate the bioavailability and steady state assessment of NKO® in a low … dose used, the clinical study establishes new grounds for the methodology of bioavailability assessment for omega-3 fatty acids. It is the first
40-F
2020 FY
NEPTF
Neptune Wellness Solutions Inc
10 Jun 20
Annual report (Canada)
4:36pm
on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes … over financial reporting as of March 31, 2020. In making this assessment, the Registrant’s management used the criteria established in Internal
40-F
2021 FY
EX-99.2
NEPTF
Neptune Wellness Solutions Inc
16 Jul 21
Annual report (Canada)
9:51am
with respect to the assessment of the removal of segment disclosure for the comparative period as described in Note 24 and, accordingly, we do not express … on the critical audit matters or on the accounts or disclosures to which they relate.
– 4 –
Goodwill impairment assessment for the Sugarleaf
8-K
NEPTF
Neptune Wellness Solutions Inc
30 May 23
Changes in Registrant's Certifying Accountant
4:01pm
accounting standards.
Ineffective risk assessment process, including (i) potential for fraud and (ii) identification and assessment of changes
6-K
EX-99.2
NEPTF
Neptune Wellness Solutions Inc
14 Jan 11
Current report (foreign)
12:00am
tables:
Phase 1 : Initial Assessment Phase
Actions
High-level assessment to identify areas of accounting differences between Canadian GAAP and IFRS … .
Rank their impact (high, medium or low priority) that may arise from the transition to IFRS.
Assessment of potential consequences on financial
6-K
EX-99.2
r5aekx
15 Oct 10
Consolidated Statements of Earnings and Comprehensive Income
12:00am
40-F
EX-99.2
s507lp2e 7w
10 Jun 20
Annual report (Canada)
4:36pm
6-K
EX-99.1
ld457 xcj2iph
4 Oct 19
Business Acquisition Report
4:20pm
40-F
EX-99.5
p9spr 0ezqldjf9qmz
31 May 11
Annual report (Canada)
12:00am
6-K
EX-99.1
8me p2mnxx3v486
28 Jan 22
Consolidated Financial Statements of
4:26pm
40FR12B
EX-99.52
m8wnbuf2 lyp0
8 Jun 07
Initial registration of securities (Canada)
12:00am
6-K
EX-99.2
5e9euco66f6anuqy1
14 Aug 19
Management Discussion and Analysis of the Financial Situation and Operating Results for the Three-month Periods Ended June 30, 2019 and 2018
12:00am
6-K
EX-99
lscyx2jh 2i5vp39q8
1 Mar 12
Form 6-K Filing Document
12:00am
40FR12B/A
EX-99.0.2
audmw87o84i55v
13 Jul 07
Initial registration of securities (Canada) (amended)
12:00am
40-F
EX-99.2
tkprwjat qkjwft
12 Jun 19
Annual report (Canada)
4:57pm
6-K
EX-99.1
fnv4dmzdtx
23 Jan 08
Neptune Technologies receives GRAS notification in the United States
12:00am
6-K
EX-99.1
89vjiy qf
16 Nov 20
Current report (foreign)
4:05pm
8-K
EX-99.2
mmuyr oj6xr5zwyajvl
7 Aug 23
Departure of Directors or Certain Officers
4:17pm
6-K
EX-99.1
ru3z q46cl
29 Sep 10
Current report (foreign)
12:00am
6-K
EX-99.1
5svi6wa
14 Apr 08
Neptune Technologies & Bioressources Inc. reports third quarter results and update on strategic milestones
12:00am